Applications of Metabolomics and Lipidomics in the Neonatal Intensive Care Unit
Authors:
- on behalf of the Stanford Metabolic Health CenterOCon behalf of the Stanford Metabolic Health Center
- 1 February 2025
- journal article
- review article
- Published by American Academy of Pediatrics (AAP) in NeoReviews
- Vol. 26 (2) , e100-e114
Abstract
The metabolome and lipidome comprise the thousands of molecular compounds in an organism. Molecular compounds consist of the upstream metabolic components of intracellular reactions or the byproducts of cellular pathways. Molecular and biochemical perturbations are associated with disorders in newborns and infants. The diagnosis of inborn errors of metabolism has relied on targeted metabolomics for several decades. Newer approaches offer the potential to identify novel biomarkers for common diseases of the newborn and infant. They may also elucidate novel predictive or diagnostic measures for a variety of health trajectories. Here, we review the relevance of the metabolome and lipidome for common disorders and highlight challenges and opportunities for future investigations.Keywords
This publication has 110 references indexed in Scilit:
- Targeted LC-MS/MS profiling of bile acids reveals primary/secondary bile acid ratio as a novel biomarker for necrotizing enterocolitisAnalytical and Bioanalytical Chemistry, 2023
- Association of High-Dose Erythropoietin With Circulating Biomarkers and Neurodevelopmental Outcomes Among Neonates With Hypoxic Ischemic EncephalopathyJAMA Network Open, 2023
- Using MetaboAnalyst 4.0 for Comprehensive and Integrative Metabolomics Data AnalysisCurrent Protocols in Bioinformatics, 2019
- High-Throughput Metabolomics2019
- Stress, inflammation, and eicosanoids: an emerging perspectiveCancer and Metastasis Reviews, 2018
- Tracheal aspirate VEGF and sphingolipid metabolites in the preterm infant with later development of bronchopulmonary dysplasiaPediatric Pulmonology, 2018
- Clinical Metabolomics2018
- Sphingolipids as cell fate regulators in lung development and diseaseApoptosis, 2015
- Translational biomarker discovery in clinical metabolomics: an introductory tutorialMetabolomics, 2012
- Challenges and opportunities of metabolomicsJournal of Cellular Physiology, 2011